Gamma-delta (gamma delta) T cell-derived cytokines (IL-4, IL-17, IFN-gamma and IL-10) and their possible implications for atopic dermatitis development

Imagem de Miniatura
Arquivos
art_FAGUNDES_Gammadelta_gamma_delta_T_cellderived_cytokines_IL4_IL17_2023.PDF (331.41 KB)
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
Citação
INTERNATIONAL JOURNAL OF DERMATOLOGY, v.62, n.4, p.443-448, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Atopic dermatitis (AD) is a chronic disease related to skin disorders that affect individuals in their childhood and can persist or start in adulthood. Patients affected by this disease commonly show skin lesions on the body surface (mainly on the upper and lower limbs) and allergic rhinitis or asthma crises. Looking at the disease from a molecular perspective, the major cytokines involved in inflammatory skin diseases, not only AD, include IL-4, IL-17, IFN-gamma and IL-10. Although they can produce these cytokines and infiltrate the affected epithelia in patients with AD, gamma delta T cells are still almost unexplored. In this update, we briefly discuss the involvement of IL-4, IL-17, IFN-gamma and IL-10 in the pathophysiology of AD and the possible role of gamma delta T cells during the inflammatory process.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/53204
Referências
  1. Batista DIS, 2015, J EUR ACAD DERMATOL, V29, P1091, DOI 10.1111/jdv.12753
  2. Bessa GR, 2016, AN BRAS DERMATOL, V91, P604, DOI 10.1590/abd1806-4841.20164860
  3. Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781
  4. Boothe WD, 2017, ADV EXP MED BIOL, V1027, P21, DOI 10.1007/978-3-319-64804-0_3
  5. Brunner PM, 2017, J ALLERGY CLIN IMMUN, V139, pS65, DOI 10.1016/j.jaci.2017.01.011
  6. Cairo C, 2005, CLIN EXP IMMUNOL, V141, P116, DOI 10.1111/j.1365-2249.2005.02813.x
  7. Castillo-Gonzalez R, 2021, J ALLERGY CLIN IMMUN, V147, P2030, DOI 10.1016/j.jaci.2020.11.023
  8. Cetinkaya PG, 2019, TURK J MED SCI, V49, P963, DOI 10.3906/sag-1810-105
  9. Chen L, 2007, J IMMUNOL, V178, P2730, DOI 10.4049/jimmunol.178.5.2730
  10. CHERNOFF AE, 1995, J IMMUNOL, V154, P5492
  11. Chieosilapatham P, 2021, CLIN EXP IMMUNOL, V204, P296, DOI 10.1111/cei.13575
  12. Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891
  13. Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877
  14. Czarnowicki T, 2014, J ALLER CL IMM-PRACT, V2, P371, DOI 10.1016/j.jaip.2014.03.006
  15. DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041
  16. de Sousa TR, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030436
  17. Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084
  18. Esaki H, 2016, J ALLERGY CLIN IMMUN, V138, P1639, DOI 10.1016/j.jaci.2016.07.013
  19. Ezzat MHM, 2011, J EUR ACAD DERMATOL, V25, P334, DOI 10.1111/j.1468-3083.2010.03794.x
  20. Felices M, 2009, P NATL ACAD SCI USA, V106, P8308, DOI 10.1073/pnas.0808459106
  21. FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0
  22. Furue M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155382
  23. Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584
  24. Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916
  25. Gros E, 2011, J ALLERGY CLIN IMMUN, V128, P1015, DOI 10.1016/j.jaci.2011.05.043
  26. Gu Siyi, 2014, Front Immunol, V5, P688, DOI 10.3389/fimmu.2014.00688
  27. Gyimesi E, 2011, J CLIN IMMUNOL, V31, P864, DOI 10.1007/s10875-011-9551-5
  28. Hahn YS, 2004, J IMMUNOL, V172, P2894, DOI 10.4049/jimmunol.172.5.2894
  29. Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446
  30. Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030
  31. Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006
  32. He WF, 2010, J IMMUNOL, V185, P126, DOI 10.4049/jimmunol.0903767
  33. HORNER AA, 1995, J EXP MED, V181, P1239, DOI 10.1084/jem.181.3.1239
  34. Howell MD, 2005, J INVEST DERMATOL, V125, P738, DOI 10.1111/j.0022-202X.2005.23776.x
  35. Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012
  36. Huang YF, 2013, J IMMUNOL, V190, P913, DOI 10.4049/jimmunol.1202230
  37. Huang YF, 2009, J IMMUNOL, V183, P849, DOI 10.4049/jimmunol.0804104
  38. Huber SA, 2000, J IMMUNOL, V165, P4174, DOI 10.4049/jimmunol.165.8.4174
  39. Izuhara K, 2017, CELL MOL LIFE SCI, V74, P4293, DOI 10.1007/s00018-017-2648-0
  40. Jee MH, 2020, IMMUNOL REV, V298, P61, DOI 10.1111/imr.12913
  41. Jin S, 2014, EXP DERMATOL, V23, P938, DOI 10.1111/exd.12563
  42. Kaesler S, 2014, J ALLERGY CLIN IMMUN, V134, P92, DOI 10.1016/j.jaci.2014.02.017
  43. Kamijo S, 2021, J INVEST DERMATOL, V141, P105, DOI 10.1016/j.jid.2020.05.088
  44. Kantor R, 2017, EXPERT REV CLIN IMMU, V13, P15, DOI 10.1080/1744666X.2016.1212660
  45. Kim BE, 2008, CLIN IMMUNOL, V126, P332, DOI 10.1016/j.clim.2007.11.006
  46. Kim J, 2019, ALLERGY ASTHMA PROC, V40, P84, DOI 10.2500/aap.2019.40.4202
  47. Kim JE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081234
  48. Konur A, 2005, BRIT J DERMATOL, V152, P1134, DOI 10.1111/j.1365-2133.2005.06508.x
  49. Langan SM, 2020, LANCET, V396, P345, DOI 10.1016/S0140-6736(20)31286-1
  50. Leonardi S, 2015, ALLERGY ASTHMA PROC, V36, P74, DOI 10.2500/aap.2015.36.3808
  51. LESTER MR, 1995, J IMMUNOL, V154, P6174
  52. Lobo-Silva D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0763-8
  53. Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706
  54. Shiromizu CM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02389
  55. MALEFYT RD, 1991, J EXP MED, V174, P1209
  56. Malik K, 2017, DERMATOL CLIN, V35, P317, DOI 10.1016/j.det.2017.02.006
  57. MCMENAMIN C, 1994, SCIENCE, V265, P1869, DOI 10.1126/science.7916481
  58. Neis MM, 2006, J ALLERGY CLIN IMMUN, V118, P930, DOI 10.1016/j.jaci.2006.07.015
  59. Nielsen MM, 2017, NAT REV IMMUNOL, V17, P733, DOI 10.1038/nri.2017.101
  60. Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262
  61. Nutten S, 2015, ANN NUTR METAB, V66, P8, DOI 10.1159/000370220
  62. OHMEN JD, 1995, J IMMUNOL, V154, P1956
  63. Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481
  64. Orfali RL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25125-0
  65. Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261
  66. Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439
  67. Qi YQ, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-019-0817-8
  68. Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717
  69. Schreiber K, 2018, NAT REV DIS PRIMERS, V4, DOI [10.1038/nrdp.2018.5, 10.1038/nrdp.2017.103]
  70. Schwingen J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030699
  71. Seneviratne SL, 2006, CLIN EXP DERMATOL, V31, P689, DOI 10.1111/j.1365-2230.2006.02172.x
  72. Sugaya M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041314
  73. Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824
  74. Svensson L, 2003, IMMUNOLOGY, V108, P98, DOI 10.1046/j.1365-2567.2003.01561.x
  75. Swindell WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-527
  76. Tokura Y, 2022, ALLERGOL INT, V71, P14, DOI 10.1016/j.alit.2021.07.003
  77. Tsybikov NN, 2015, ALLERGY ASTHMA PROC, V36, pE140, DOI 10.2500/aap.2015.36.3901
  78. Waldman AR, 2018, PEDIATR REV, V39, P180, DOI 10.1542/pir.2016-0169
  79. Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X
  80. Werfel T, 2016, J ALLERGY CLIN IMMUN, V138, P336, DOI 10.1016/j.jaci.2016.06.010
  81. Wu YL, 2014, INT J BIOL SCI, V10, P119, DOI 10.7150/ijbs.7823
  82. Yamanaka K, 2011, CURR PROBL DERMATOL, V41, P80, DOI 10.1159/000323299
  83. Yamazaki Y, 2017, ALLERGOL INT, V66, P539, DOI 10.1016/j.alit.2017.08.004
  84. Zhao J, 2019, GENET TEST MOL BIOMA, V23, P332, DOI 10.1089/gtmb.2018.0276
  85. Zuany-Amorim C, 1998, SCIENCE, V280, P1265, DOI 10.1126/science.280.5367.1265

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/56
Artigos e Materiais de Revistas Científicas - ODS/03